crane co - CR
CR
Close Chg Chg %
179.93 0.08 0.04%
Closed Market
180.01
+0.08 (0.04%)
Volume: 323.47K
Last Updated:
Oct 3, 2025, 3:59 PM EDT
Company Overview: crane co - CR
CR Key Data
| Open $179.99 | Day Range 179.29 - 182.00 |
| 52 Week Range 127.04 - 203.75 | Market Cap $10.36B |
| Shares Outstanding 57.55M | Public Float 56.99M |
| Beta 1.23 | Rev. Per Employee N/A |
| P/E Ratio 33.96 | EPS $5.38 |
| Yield 49.72% | Dividend $0.23 |
| EX-DIVIDEND DATE Aug 29, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 302.94K |
CR Performance
| 1 Week | -1.15% | ||
| 1 Month | -2.36% | ||
| 3 Months | -6.85% | ||
| 1 Year | 13.04% | ||
| 5 Years | N/A |
CR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
10
Full Ratings ➔
About crane co - CR
Crane Co. designs and manufactures aerospace, electronics & engineered industrial products. It operates through four segments: Aerospace & Electronics, Process Flow Technologies, Payment & Merchandising Technology, and Engineered Materials. The company was founded by Richard Teller Crane on July 4, 1855 and is headquartered in Stamford, CT.
CR At a Glance
Crane Co.
100 First Stamford Place
Stamford, Connecticut 06902
| Phone | 1-203-363-7300 | Revenue | 2.13B | |
| Industry | Aerospace & Defense | Net Income | 294.70M | |
| Sector | Electronic Technology | 2024 Sales Growth | 2.147% | |
| Fiscal Year-end | 12 / 2025 | Employees | 7,300 | |
| View SEC Filings |
CR Valuation
| P/E Current | 33.963 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 30.02 |
| Price to Sales Ratio | 4.151 |
| Price to Book Ratio | 5.305 |
| Price to Cash Flow Ratio | 32.43 |
| Enterprise Value to EBITDA | 21.784 |
| Enterprise Value to Sales | 4.158 |
| Total Debt to Enterprise Value | 0.036 |
CR Efficiency
| Revenue/Employee | 291,945.205 |
| Income Per Employee | 40,369.863 |
| Receivables Turnover | 5.229 |
| Total Asset Turnover | 0.857 |
CR Liquidity
| Current Ratio | 2.582 |
| Quick Ratio | 1.882 |
| Cash Ratio | 0.564 |
CR Profitability
| Gross Margin | 40.719 |
| Operating Margin | 16.695 |
| Pretax Margin | 15.883 |
| Net Margin | 13.828 |
| Return on Assets | 10.781 |
| Return on Equity | 17.901 |
| Return on Total Capital | 13.698 |
| Return on Invested Capital | 14.869 |
CR Capital Structure
| Total Debt to Total Equity | 19.485 |
| Total Debt to Total Capital | 16.307 |
| Total Debt to Total Assets | 12.086 |
| Long-Term Debt to Equity | 18.692 |
| Long-Term Debt to Total Capital | 15.644 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Crane Co - CR
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 3.18B | 2.04B | 2.09B | 2.13B | |
Sales Growth
| +15.16% | -36.01% | +2.53% | +2.15% | |
Cost of Goods Sold (COGS) incl D&A
| 1.94B | 1.32B | 1.28B | 1.26B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 119.50M | 39.60M | 39.30M | 51.00M | |
Depreciation
| 75.00M | 33.90M | 33.00M | 33.40M | |
Amortization of Intangibles
| 44.50M | 5.70M | 6.30M | 17.60M | |
COGS Growth
| +7.95% | -31.85% | -3.03% | -1.40% | |
Gross Income
| 1.24B | 713.60M | 805.00M | 867.80M | |
Gross Income Growth
| +28.59% | -42.50% | +12.81% | +7.80% | |
Gross Profit Margin
| +39.03% | +35.07% | +38.58% | +40.72% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 755.60M | 478.80M | 521.20M | 512.00M | |
Research & Development
| 81.40M | 49.20M | 55.90M | 46.10M | |
Other SG&A
| 674.20M | 429.60M | 465.30M | 465.90M | |
SGA Growth
| +11.07% | -36.63% | +8.86% | -1.77% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | (16.90M) | 4.20M | - |
EBIT after Unusual Expense
| 502.30M | 230.60M | 283.80M | 355.80M | |
Non Operating Income/Expense
| 21.80M | 94.30M | 5.90M | 9.90M | |
Non-Operating Interest Income
| 1.40M | 17.60M | 5.10M | 5.50M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 46.90M | 10.30M | 22.70M | 27.20M | |
Interest Expense Growth
| -15.19% | -78.04% | +120.39% | +19.82% | |
Gross Interest Expense
| 46.90M | 10.30M | 22.70M | 27.20M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 477.20M | 314.60M | 267.00M | 338.50M | |
Pretax Income Growth
| +136.47% | -34.07% | -15.13% | +26.78% | |
Pretax Margin
| +15.01% | +15.46% | +12.80% | +15.88% | |
Income Tax
| 82.90M | 114.80M | 63.20M | 70.30M | |
Income Tax - Current - Domestic
| 37.90M | 23.50M | 48.60M | 43.70M | |
Income Tax - Current - Foreign
| 34.20M | 75.70M | 36.10M | 38.20M | |
Income Tax - Deferred - Domestic
| 10.20M | 16.40M | (17.30M) | (9.10M) | |
Income Tax - Deferred - Foreign
| 600.00K | (800.00K) | (4.20M) | (2.50M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 394.30M | 199.80M | 203.80M | 268.20M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 394.30M | 199.80M | 203.80M | 268.20M | |
Net Income Growth
| +141.75% | -49.33% | +2.00% | +31.60% | |
Net Margin Growth
| +12.40% | +9.82% | +9.77% | +12.58% | |
Extraordinaries & Discontinued Operations
| - | 41.10M | 52.10M | 26.50M | |
Discontinued Operations
| - | 41.10M | 52.10M | 26.50M | |
Net Income After Extraordinaries
| 435.40M | 199.80M | 255.90M | 294.70M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 435.40M | 199.80M | 255.90M | 294.70M | |
EPS (Basic)
| 7.4555 | 3.5222 | 4.5132 | 5.1521 | |
EPS (Basic) Growth
| +140.14% | -52.76% | +28.14% | +14.16% | |
Basic Shares Outstanding
| 58.40M | 56.73M | 56.70M | 57.20M | |
EPS (Diluted)
| 7.3547 | 3.5222 | 4.4504 | 5.0549 | |
EPS (Diluted) Growth
| +138.93% | -52.11% | +26.35% | +13.58% | |
Diluted Shares Outstanding
| 59.20M | 56.73M | 57.50M | 58.30M | |
EBITDA
| 604.90M | 274.40M | 323.10M | 406.80M | |
EBITDA Growth
| +48.04% | -54.64% | +17.75% | +25.91% | |
EBITDA Margin
| +19.02% | +13.48% | +15.49% | +19.09% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 217.857 | |
| Number of Ratings | 10 | Current Quarters Estimate | 1.424 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 5.776 | |
| Last Quarter’s Earnings | 1.455 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 4.88 | Next Fiscal Year Estimate | 6.47 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 2 | 7 | 7 |
| Mean Estimate | 1.42 | 1.49 | 5.78 | 6.47 |
| High Estimates | 1.51 | 1.50 | 5.95 | 6.84 |
| Low Estimate | 1.38 | 1.48 | 5.70 | 6.18 |
| Coefficient of Variance | 3.31 | 1.05 | 1.47 | 3.51 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 6 |
| OVERWEIGHT | 1 | 1 | 2 |
| HOLD | 3 | 3 | 2 |
| UNDERWEIGHT | 0 | 0 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Crane Co - CR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Crane Co - CR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 2, 2025 | James Luther Lyman Tullis Director | 32,322 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Susan Diane Lynch Director | 1,723 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Susan Diane Lynch Director | 1,720 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Sanjay Kapoor Director | 6,514 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Sanjay Kapoor Director | 6,541 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ellen McClain Haime Director | 23,897 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ellen McClain Haime Director | 23,782 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Martin R. Benante Director | 19,120 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Martin R. Benante Director | 19,028 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Martin R. Benante Director | 1,776 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Charles G. McClure Director | 18,056 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | James Luther Lyman Tullis Director | 32,161 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ronald Carter Lindsay Director | 27,638 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ronald Carter Lindsay Director | 27,504 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Jennifer M. Pollino Director | 22,997 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Jennifer M. Pollino Director | 22,886 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Charles G. McClure Director | 18,143 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 17, 2025 | Marijane Papanikolaou V.P., Controller & CAO | 2,114 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 17, 2025 | Max Homer Mitchell Chairman, President and CEO; Director | 21,097 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 17, 2025 | Max Homer Mitchell Chairman, President and CEO; Director | 391,351 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $172 per share | 67,312,372.00 |